<unk>  refers to a treatment regimen consisting of a combination of cyclophosphamide, bortezomib (Velcade) and dexamethasone three-drug induction regimen for untreated transplant-eligible multiple myeloma patients and AL amyloidosis
CyBorD regimen
CBV regimen
TAC regimen
R-CDOP regimen
R-CVP regimen
CHOP regimen
TIP regimen
ICE-R regimen